PCVX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

10.09

Margin Of Safety %

Put/Call OI Ratio

2.82

EPS Next Q Diff

-0.19

EPS Last/This Y

-2.85

EPS This/Next Y

1.06

Price

58.08

Target Price

109

Analyst Recom

1.2

Performance Q

12.86

Upside

-564.5%

Beta

1.22

Ticker: PCVX

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-13	PCVX	57.01	3.00	0.50	94544
2026-07-14	PCVX	56.19	2.98	0.84	94774
2026-07-15	PCVX	56.7	2.91	0.02	95551
2026-07-16	PCVX	56.02	2.88	0.04	95833
2026-07-17	PCVX	56.26	2.88	0.59	95782
2026-07-20	PCVX	55.68	2.94	3.29	90061
2026-07-21	PCVX	58.06	2.93	2.41	90136
2026-07-22	PCVX	55.99	2.93	1.74	90193
2026-07-23	PCVX	55.66	2.93	0.13	90270
2026-07-24	PCVX	54.65	2.92	0.50	90350
2026-07-27	PCVX	55.52	2.92	0.00	90436
2026-07-28	PCVX	54.58	2.92	0.30	90442
2026-07-29	PCVX	52.99	2.92	0.76	90449
2026-07-30	PCVX	55.98	2.91	0.50	90473
2026-07-31	PCVX	54.06	2.90	0.00	90667
2026-08-03	PCVX	53.49	2.90	0.43	90652
2026-08-04	PCVX	54.7	2.90	1.22	90703
2026-08-05	PCVX	55.93	2.87	0.00	91584
2026-08-06	PCVX	58.99	2.82	0.87	92007
2026-08-07	PCVX	58.11	2.82	0.13	92043
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-13	PCVX	56.98	-71.9	-	-8.48
2026-07-14	PCVX	56.19	-71.9	-	-8.48
2026-07-15	PCVX	56.72	-71.9	-	-8.48
2026-07-16	PCVX	55.98	-71.9	-	-8.48
2026-07-17	PCVX	56.20	-71.9	-	-8.48
2026-07-20	PCVX	55.49	-71.9	-	-8.48
2026-07-21	PCVX	58.04	-71.9	-	-8.48
2026-07-22	PCVX	55.99	-71.9	-	-8.48
2026-07-23	PCVX	55.65	-71.9	-	-8.48
2026-07-24	PCVX	54.60	-71.9	-	-8.48
2026-07-27	PCVX	55.50	-71.9	-	-8.48
2026-07-28	PCVX	54.57	-71.9	-	-8.48
2026-07-29	PCVX	52.93	-71.9	-	-8.48
2026-07-30	PCVX	55.96	-71.9	-	-8.48
2026-07-31	PCVX	54.07	-71.9	-	-8.48
2026-08-03	PCVX	53.54	-71.9	-	-8.48
2026-08-04	PCVX	53.54	-71.9	-	-8.48
2026-08-05	PCVX	55.83	-71.9	-	-8.48
2026-08-06	PCVX	58.94	-71.9	-	-8.48
2026-08-07	PCVX	58.08	-71.9	-	-8.48
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-13	PCVX	-2.61	9.94	12.39
2026-07-14	PCVX	-2.61	9.94	12.39
2026-07-15	PCVX	-2.61	9.94	12.39
2026-07-16	PCVX	-2.61	9.94	12.39
2026-07-17	PCVX	-2.61	9.94	12.39
2026-07-20	PCVX	-2.61	9.85	12.39
2026-07-21	PCVX	-2.61	9.85	12.39
2026-07-22	PCVX	-2.61	9.85	12.39
2026-07-23	PCVX	-2.61	9.85	12.39
2026-07-24	PCVX	-2.61	9.85	12.39
2026-07-27	PCVX	-2.61	9.85	10.10
2026-07-28	PCVX	-2.61	9.85	10.10
2026-07-29	PCVX	-3.11	9.85	10.10
2026-07-30	PCVX	-3.11	9.85	10.10
2026-07-31	PCVX	-3.11	9.85	10.10
2026-08-03	PCVX	-3.11	9.98	10.09
2026-08-04	PCVX	-3.23	9.98	10.09
2026-08-05	PCVX	-3.57	9.98	10.09
2026-08-06	PCVX	-4.04	9.98	10.09
2026-08-07	PCVX	-4.04	9.98	10.09
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-1.97

Avg. EPS Est. Current Quarter

-2.1

Avg. EPS Est. Next Quarter

-2.16

Insider Transactions

-4.04

Institutional Transactions

9.98

Beta

1.22

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-76.2

Target Price

109

P/E

Forward P/E

PEG

P/S

P/B

3.05

P/Free Cash Flow

EPS

-7.71

Average EPS Est. Cur. Y

-8.48

EPS Next Y. (Est.)

-7.42

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.84

Return on Equity vs Sector %

-65.9

Return on Equity vs Industry %

-49.8

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ PCVX Healthcare

$58.10

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

20/20

Pullback

12/25

Volume

7/15

Valuation

9/20

TP/AR

2/10

Options

4/10

RSI

57.1

Range 1M

67.4%

Sup Dist

3.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

11/25

Growth

8/30

Estimates

0/20

Inst/Vol

8/15

Options

4/10

EPS Yr

-46.9%

EPS NY

20.5%

52W%

79.9%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +87.6% upside

Quality

2/30

Valuation

15/30

Growth

6/25

Stability

9/10

LT Trend

4/5

Upside

+87.6%

Quality

PCVX — P/E HistoricalBiotechnology

Vaxcyte, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 507

Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV for the prevention of IPD in adults and children; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting the keystone pathogen responsible for periodontitis; VAX-GI, a novel preclinical vaccine candidate for the treatment of dysentery and shigellosis, which is caused by Shigella bacteria; and VAX-XL, a third-generation pneumococcal conjugate vaccine. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.

PCVX

Latest News

—

Caricamento notizie per PCVX…

stock quote shares PCVX – Vaxcyte Inc. Stock Price stock today

news today PCVX – Vaxcyte Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch PCVX – Vaxcyte Inc. yahoo finance google finance

stock history PCVX – Vaxcyte Inc. invest stock market

stock prices PCVX premarket after hours

ticker PCVX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: PCVX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y